Expert perspectives on the identification and management of metastatic castrate-sensitive prostate cancer in a 67-year-old man.
EP. 1: Case Overview: A 67-Year-Old Man With Metastatic CSPC
Watch
EP. 2: Case Overview: Metastatic CSPC Follow-Up and Management
EP. 3: MCSPC: Treatment After Progression on AR-Targeted Therapy
EP. 4: CARD Trial: Cabazitaxel After AR-Targeted Therapy in mCSPC
EP. 5: Managing AEs in Metastatic CSPC: TROPIC and CARD Trials
EP. 6: CARD Trial: How Does CSPC Progress to CRPC?